Source: Abstracts. Conference titles: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology/SBBQ. Unidade: IQ
Assunto: MEDICAMENTO
ABNT
GOMES, Rafaela Pino et al. Simvastatin‐mediated temozolomide responsiveness in aggressive mesenchymal/ IDH‐ wildtype human glioblastoma. 2025, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Celular, 2025. Disponível em: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf. Acesso em: 02 dez. 2025.APA
Gomes, R. P., Ribas, H. T., Souza, J. V. S. de, Ribeiro, C. S. P., Bellan, D. de L., Trindade, E. da S., et al. (2025). Simvastatin‐mediated temozolomide responsiveness in aggressive mesenchymal/ IDH‐ wildtype human glioblastoma. In Abstracts. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Celular. Recuperado de https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdfNLM
Gomes RP, Ribas HT, Souza JVS de, Ribeiro CSP, Bellan D de L, Trindade E da S, Sogayar MC, Lima MT, Martinez GR, Winnischofer SMB. Simvastatin‐mediated temozolomide responsiveness in aggressive mesenchymal/ IDH‐ wildtype human glioblastoma [Internet]. Abstracts. 2025 ;[citado 2025 dez. 02 ] Available from: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdfVancouver
Gomes RP, Ribas HT, Souza JVS de, Ribeiro CSP, Bellan D de L, Trindade E da S, Sogayar MC, Lima MT, Martinez GR, Winnischofer SMB. Simvastatin‐mediated temozolomide responsiveness in aggressive mesenchymal/ IDH‐ wildtype human glioblastoma [Internet]. Abstracts. 2025 ;[citado 2025 dez. 02 ] Available from: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf
